These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1379529)

  • 21. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The combined effects of interleukin-11, stem cell factor, and granulocyte colony-stimulating factor on newborn rat hematopoiesis: significant enhancement of the absolute neutrophil count.
    Cairo MS; Plunkett JM; Schendel P; van de Ven C
    Exp Hematol; 1994 Oct; 22(11):1118-23. PubMed ID: 7523164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Granulocyte colony-stimulating factor versus placebo in addition to penicillin G in a randomized blinded study of gram-negative pneumonia sepsis: analysis of survival and multisystem organ failure.
    Smith WS; Sumnicht GE; Sharpe RW; Samuelson D; Millard FE
    Blood; 1995 Aug; 86(4):1301-9. PubMed ID: 7543303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-dose continuous subcutaneous infusion of granulocyte colony-stimulating factor for chemotherapy-induced neutropenia in acute myelogenous leukemia and its pharmacokinetics.
    Ikeda K; Tasaka T; Sasaki K; Murata M; Kitanaka A; Nagai M; Kawanishi K; Takahara J; Irino S
    Leukemia; 1994 Nov; 8(11):1838-41. PubMed ID: 7526087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Critical influence of timing of administration of granulocyte colony-stimulating factor on antibacterial effect in experimental endocarditis due to Pseudomonas aeruginosa.
    Vignes S; Fantin B; Elbim C; Walker F; Gougerot-Pocidalo MA; Carbon C
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2702-7. PubMed ID: 8593006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kinetic response of human marrow myeloid progenitor cells to in vivo treatment of patients with granulocyte colony-stimulating factor is different from the response to treatment with granulocyte-macrophage colony-stimulating factor.
    Broxmeyer HE; Benninger L; Patel SR; Benjamin RS; Vadhan-Raj S
    Exp Hematol; 1994 Jan; 22(1):100-2. PubMed ID: 7506671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Protective effect of KW-2228 in a systemic infection model of CPA-treated tumor-bearing mice].
    Yoshino T; Sato K
    Jpn J Antibiot; 1992 Jan; 45(1):87-90. PubMed ID: 1379651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Granulocyte colony-stimulating factor improves survival rate and reduces concentrations of bacteria, endotoxin, tumor necrosis factor, and endothelin-1 in fulminant intra-abdominal sepsis in rats.
    Lundblad R; Nesland JM; Giercksky KE
    Crit Care Med; 1996 May; 24(5):820-6. PubMed ID: 8706460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of teicoplanin and G-CSF on survival in experimental MRSA pneumonia in neutropenic mice.
    Oz N; Agalar C; Daphan CE; Agalar F; Turkyilmaz R
    Int J Surg Investig; 2001; 2(5):347-52. PubMed ID: 12678538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Granulocyte colony stimulating factor (G-CSF) as an adjunct to antibiotics in the treatment of pneumonia in adults.
    Cheng AC; Stephens DP; Currie BJ
    Cochrane Database Syst Rev; 2003; (4):CD004400. PubMed ID: 14584011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase I study of intravenously administered bacterially synthesized granulocyte-macrophage colony-stimulating factor and comparison with subcutaneous administration.
    Lieschke GJ; Maher D; O'Connor M; Green M; Sheridan W; Rallings M; Bonnem E; Burgess AW; McGrath K; Fox RM
    Cancer Res; 1990 Feb; 50(3):606-14. PubMed ID: 2404573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor after high-dose cyclophosphamide cancer therapy.
    Bregni M; Siena S; Di Nicola M; Dodero A; Peccatori F; Ravagnani F; Danesini G; Laffranchi A; Bonadonna G; Gianni AM
    J Clin Oncol; 1996 Feb; 14(2):628-35. PubMed ID: 8636780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hematologic effects of recombinant murine granulocyte-macrophage colony-stimulating factor on the peripheral blood and bone marrow.
    Ulich TR; del Castillo J; McNiece I; Watson L; Yin SM; Andresen J
    Am J Pathol; 1990 Aug; 137(2):369-76. PubMed ID: 1696784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative effects of three cytokine regimens after high-dose cyclophosphamide: granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor (GM-CSF), and sequential interleukin-3 and GM-CSF.
    Ballestrero A; Ferrando F; Garuti A; Basta P; Gonella R; Stura P; Mela GS; Sessarego M; Gobbi M; Patrone F
    J Clin Oncol; 1999 Apr; 17(4):1296. PubMed ID: 10561192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell processing protocol for allogeneic peripheral blood stem cells mobilized by granulocyte colony-stimulating factor.
    Suzue T; Kawano Y; Takaue Y; Kuroda Y
    Exp Hematol; 1994 Aug; 22(9):888-92. PubMed ID: 7520392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Study of the prophylactic effect of human granulocyte-colony stimulating factor (G-CSF) on experimental pyelonephritis induced by Pseudomonas aeruginosa in diabetic mice].
    Yokoo A; Kumamoto Y; Hirose T; Tanaka N
    Kansenshogaku Zasshi; 1989 Jul; 63(7):738-47. PubMed ID: 2482317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of recombinant granulocyte colony-stimulating factor (rG-CSF) and recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF) on acute radiation hematopoietic injury in mice.
    Tanikawa S; Nakao I; Tsuneoka K; Nara N
    Exp Hematol; 1989 Sep; 17(8):883-8. PubMed ID: 2475360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized cross-over trial of progenitor-cell mobilization: high-dose cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor plus G-CSF.
    Koç ON; Gerson SL; Cooper BW; Laughlin M; Meyerson H; Kutteh L; Fox RM; Szekely EM; Tainer N; Lazarus HM
    J Clin Oncol; 2000 May; 18(9):1824-30. PubMed ID: 10784622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of prophylactic administration of recombinant human granulocyte colony-stimulating factor (filgrastim) on the frequency of nosocomial infections in patients with acute traumatic brain injury or cerebral hemorrhage. The Filgrastim Study Group.
    Heard SO; Fink MP; Gamelli RL; Solomkin JS; Joshi M; Trask AL; Fabian TC; Hudson LD; Gerold KB; Logan ED
    Crit Care Med; 1998 Apr; 26(4):748-54. PubMed ID: 9559614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.